Literature DB >> 21907396

Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.

Andrea Maneo1, Mario Sideri, Giovanni Scambia, Sara Boveri, Tiziana Dell'anna, Mario Villa, Gabriella Parma, Anna Fagotti, Francesco Fanfani, Fabio Landoni.   

Abstract

OBJECTIVES: Simple conization represents a plausible treatment scheme for managing stage IA1-2 tumors conservatively. However its curative potential has not been widely exploited as regards stage IB1 lesions. Recent studies suggest that, in selected circumstances, patients with stage IB1 disease undergoing radical hysterectomy could have been safely cured by simple hysterectomy and even by cervical conization.
METHODS: Patients with stage IB1 cervical cancer desiring conservative management underwent simple conization and pelvic lymphadenectomy in three Italian institutes.
RESULTS: Thirty-six women received the conservative treatment since 1995 to 2010. Median age was 31 (range 24-40) years and median tumor size was 11.7 mm (range 8-25 mm). Adenocarcinoma was present in 12 cases (33%) and grade 3 neoplasia in 5 (14%). Lymph-vascular space involvement was detected in five patients (14%). Eleven had already a child while two had experienced an early abortion and a fetal loss at second trimester. After a median follow-up of 66 months (range 6-168) only one pelvic lymphnodal relapse was observed. Twenty-one pregnancies occurred in 17 patients and 14 live babies have been born (two preterm at 27 and 32 weeks) while one is ongoing. Three first-trimester miscarriages, one second-trimester fetal loss, an ectopic pregnancy and a termination of pregnancy have been recorded. Five patients decided to undergo hysterectomy after 3-12 years after conservative therapy: in one residual microinvasive adenocarcinoma was found.
CONCLUSIONS: Cervical conization represents a feasible conservative management of stage IB1 cervical cancer and shows a low risk of relapse, provided that patients are selected carefully. Conization would be suitable to treat stage IB lesions smaller than 15-20mm. with pathologic negative lymphnodes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21907396     DOI: 10.1016/j.ygyno.2011.08.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

1.  Predictive Factors for Residual Disease After Conization in Cervical Cancer.

Authors:  Glauco Baiocchi; Thiago Pereira Diniz; Graziele Bovolim; Bruna Tirapelli Gonçalves; Lillian Yuri Kumagai; Henrique Mantoan; Carlos Chaves Faloppa; Andrea Paiva Gadelha Guimaraes; Alexandre Andre Balieiro Anastacio da Costa; Levon Badiglian-Filho; Louise De Brot
Journal:  Ann Surg Oncol       Date:  2021-02-10       Impact factor: 5.344

2.  Surveillance patterns of cervical cancer patients treated with conization alone.

Authors:  Silvana Pedra Nobre; Varvara Mazina; Alexia Iasonos; Qin C Zhou; Yukio Sonoda; Ginger Gardner; Kara Long-Roche; Mario M Leitao; Nadeem R Abu-Rustum; Jennifer J Mueller
Journal:  Int J Gynecol Cancer       Date:  2020-06-03       Impact factor: 3.437

3.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

4.  New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.

Authors:  Andres A Roma; Toni-Ann Mistretta; Andrea Diaz De Vivar; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Norihiro Teramoto; Rouba Ali-Fehmi; Denise Barbuto; Joanne K L Rutgers; Elvio G Silva
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

5.  Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review.

Authors:  Brigitte Gerstl; Elizabeth Sullivan; Marcus Vallejo; Jana Koch; Maximilian Johnson; Handan Wand; Kate Webber; Angela Ives; Antoinette Anazodo
Journal:  J Cancer Surviv       Date:  2019-04-17       Impact factor: 4.442

Review 6.  Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?

Authors:  Pedro T Ramirez; Rene Pareja; Gabriel J Rendón; Carlos Millan; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-09-14       Impact factor: 5.482

Review 7.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

8.  Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion.

Authors:  Jung-Yun Lee; Jina Youm; Jae-Weon Kim; Jeong Yeon Cho; Min A Kim; Tae Hun Kim; Dong Hoon Suh; Myong Cheol Lim; Noh Hyun Park; Yong-Sang Song
Journal:  BMC Cancer       Date:  2015-03-22       Impact factor: 4.430

9.  Sexual and Reproductive Outcomes in Early Stage Cervical Cancer Patients after Excisional Cone as a Fertility-sparing Surgery: An Italian Experience.

Authors:  Francesco Fanfani; Fabio Landoni; Maria Lucia Gagliardi; Anna Fagotti; Eleonora Preti; Maria Cristina Moruzzi; Giorgia Monterossi; Giovanni Scambia
Journal:  J Reprod Infertil       Date:  2014-01

10.  Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (≤2 cm) cervical cancer.

Authors:  Huimin Bai; Dongyan Cao; Fang Yuan; Huilan Wang; Meizhu Xiao; Jie Chen; Quancai Cui; Keng Shen; Zhenyu Zhang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.